BEBT-109

SI-7853

BEBT-109, >98% (HPLC)

CAS No. : [2050906-40-4]

IUPAC Name : N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(5-methoxy-1H-pyrrolo[3,2-b]pyridin-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : BEBT‑109 is a pan‑mutant‑selective EGFR inhibitor with strong potency and improved pharmacokinetic behavior. Its broad activity against multiple oncogenic EGFR mutations makes it a valuable tool for investigating mutant‑EGFR–driven NSCLC biology and therapeutic strategies.

References : Fan F. et al: Transl Oncol., 14(2), 100961, 2021.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.